Search results: Sage Journals

Free accessResearch articleFirst published March, 2024

Determination of Time in Range Associated With HbA1c ≤7% in a Prospective Cohort of Patients With Type 1 Diabetes Using Continuous Glucose Monitoring for Three Months

Ana María Gómez, Diana Cristina Henao C, Martín Rebolledo [...]

Journal of Diabetes Science and Technology

Available accessBrief reportFirst published 2026

MiniMed ™ 780G System Users Achieve Similar Glycemic Outcomes Regardless of Socioeconomic Disadvantage

Margaret Liu, Fang Niu, Caroline Yovanovich [...]

Diabetes Technology & Therapeutics

Open accessResearch articleFirst published January, 2026

Continuous Glucose Monitoring-Based Metrics with Once-Weekly Insulin Icodec Versus Once-Daily Basal Insulins in Japanese Individuals with Type 2 Diabetes: Post Hoc Analysis of ONWARDS 1,2,and 4

Rimei Nishimura, Thaís M. Pagliaro Rocha, Yuka Hayashizaki [...]

Diabetes Technology and Obesity Medicine

Available accessResearch articleFirst published 2026

Differences in Achieving Stringent Glycemic Targets Among Youth with Type 1 Diabetes: A SWEET Registry Study

Klemen Dovc, Beata Mianowska, Claudia Boettcher [...]

Diabetes Technology & Therapeutics

Free accessResearch articleFirst published September, 2022

Comparing Patch vs Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and Profiles

Richard M. Bergenstal, Mary L. Johnson, Vanita R. Aroda [...]

Journal of Diabetes Science and Technology

Available accessResearch articleFirst published 2026

Quality-Score (Q-Score) Can Be More Sensitive than %Time in Range and Several Other CGM Metrics in Detecting Responses to Therapeutic Interventions

David Rodbard, Petra Augstein, Peter Heinke [...]

Diabetes Technology & Therapeutics

Available accessResearch articleFirst published March, 2024

A Comparison of Continuous Glucose Monitoring-Measured Time-in-Range 70–180 mg/dL Versus Time-in-Tight-Range 70–140 mg/dL

Roy W. Beck, Dan Raghinaru, Peter Calhoun [...]

Diabetes Technology & Therapeutics

Available accessBrief reportFirst published May, 2024

The Relationship Between Glycated Hemoglobin and Time in Range in a Pediatric Population

Mathilde Vandenbempt, Hanne Matheussen, Sara Charleer [...]

Diabetes Technology & Therapeutics

Open accessBrief reportFirst published March, 2021

Glycemic Improvement Using Continuous Glucose Monitoring by Baseline Time in Range: Subgroup Analyses from the DIAMOND Type 1 Diabetes Study

Peter Calhoun, David Price, Roy W. Beck

Diabetes Technology & Therapeutics

Available accessResearch articleFirst published November, 2022

Association Between Time in Range and Postprandial Glucose Contribution Rate in Non-Insulin-Treated Type 2 Diabetes Patients: Inverse Correlation of Time in Range with Postprandial Glucose Contribution Rate

Fumi Uemura, Yosuke Okada, Keiichi Torimoto [...]

Diabetes Technology & Therapeutics

Free accessResearch articleFirst published March, 2024

Determination of Time in Range Associated With HbA1c ≤7% in a Prospective Cohort of Patients With Type 1 Diabetes Using Continuous Glucose Monitoring for Three Months

Ana María Gómez, Diana Cristina Henao C, Martín Rebolledo [...]

Journal of Diabetes Science and Technology

Available accessBrief reportFirst published 2026

MiniMed ™ 780G System Users Achieve Similar Glycemic Outcomes Regardless of Socioeconomic Disadvantage

Margaret Liu, Fang Niu, Caroline Yovanovich [...]

Diabetes Technology & Therapeutics

Open accessResearch articleFirst published January, 2026

Continuous Glucose Monitoring-Based Metrics with Once-Weekly Insulin Icodec Versus Once-Daily Basal Insulins in Japanese Individuals with Type 2 Diabetes: Post Hoc Analysis of ONWARDS 1,2,and 4

Rimei Nishimura, Thaís M. Pagliaro Rocha, Yuka Hayashizaki [...]

Diabetes Technology and Obesity Medicine

Available accessResearch articleFirst published 2026

Differences in Achieving Stringent Glycemic Targets Among Youth with Type 1 Diabetes: A SWEET Registry Study

Klemen Dovc, Beata Mianowska, Claudia Boettcher [...]

Diabetes Technology & Therapeutics

Free accessResearch articleFirst published September, 2022

Comparing Patch vs Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and Profiles

Richard M. Bergenstal, Mary L. Johnson, Vanita R. Aroda [...]

Journal of Diabetes Science and Technology

Available accessResearch articleFirst published 2026

Quality-Score (Q-Score) Can Be More Sensitive than %Time in Range and Several Other CGM Metrics in Detecting Responses to Therapeutic Interventions

David Rodbard, Petra Augstein, Peter Heinke [...]

Diabetes Technology & Therapeutics

Available accessResearch articleFirst published March, 2024

A Comparison of Continuous Glucose Monitoring-Measured Time-in-Range 70–180 mg/dL Versus Time-in-Tight-Range 70–140 mg/dL

Roy W. Beck, Dan Raghinaru, Peter Calhoun [...]

Diabetes Technology & Therapeutics

Available accessBrief reportFirst published May, 2024

The Relationship Between Glycated Hemoglobin and Time in Range in a Pediatric Population

Mathilde Vandenbempt, Hanne Matheussen, Sara Charleer [...]

Diabetes Technology & Therapeutics

Open accessBrief reportFirst published March, 2021

Glycemic Improvement Using Continuous Glucose Monitoring by Baseline Time in Range: Subgroup Analyses from the DIAMOND Type 1 Diabetes Study

Peter Calhoun, David Price, Roy W. Beck

Diabetes Technology & Therapeutics

Available accessResearch articleFirst published November, 2022

Association Between Time in Range and Postprandial Glucose Contribution Rate in Non-Insulin-Treated Type 2 Diabetes Patients: Inverse Correlation of Time in Range with Postprandial Glucose Contribution Rate

Fumi Uemura, Yosuke Okada, Keiichi Torimoto [...]

Diabetes Technology & Therapeutics